Mercado mundial de la presbicia: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado

En los últimos años, se prevé que el mercado de la presbicia prolifere durante el período de pronóstico. La presbicia es la pérdida gradual de la capacidad de los ojos para enfocar objetos adyacentes. La presbicia suele aparecer entre los 40 y los 45 años y empeora hasta los 65. Si bien las terapias de corrección de la visión para problemas oculares comunes, como la miopía y la hipermetropía, suelen producir resultados excelentes, el tratamiento de la presbicia que se encuentra actualmente en el mercado tiene mucho margen de mejora. Aunque existen tratamientos para la presbicia, los resultados no han resultado convincentes. Esto ofrece más oportunidades para que el mercado de la presbicia crezca.

Data Bridge Market Research analiza que el mercado de la presbicia se valoró en USD 9.441 millones en 2021 y se espera que alcance los USD 13.840 millones para 2029, registrando una CAGR del 4,90% durante el período de pronóstico de 2022 a 2029. El informe de mercado curado por el equipo de Data Bridge Market Research incluye un análisis profundo de expertos, epidemiología de pacientes, análisis de cartera, análisis de precios y marco regulatorio.

Definición de mercado

La presbicia es una enfermedad ocular en la que la capacidad de enfocar rápidamente objetos cercanos se deteriora gradualmente. Es consecuencia del envejecimiento. El cristalino natural que se encuentra dentro del ojo se engrosa y pierde flexibilidad con el tiempo. La presbicia se debe a un problema en el cristalino del ojo, que se encuentra debajo del iris (la zona coloreada) y la pupila. El cristalino del ojo desvía (o refracta) la luz para enfocarla directamente sobre la retina, que es el tejido sensible a la luz que se encuentra en la parte posterior del ojo.

Alcance del informe y segmentación del mercado

Dinámica del mercado de la presbicia

Conductores

• Aumento de la prevalencia de enfermedades crónicas

Se estima que la creciente prevalencia de enfermedades crónicas en todo el mundo impulsará el crecimiento del mercado. Las enfermedades crónicas como la esclerosis múltiple , la diabetes o las enfermedades cardiovasculares aumentarán el riesgo de presbicia prematura, lo que impulsará la tasa de crecimiento del mercado de la presbicia. Según la Organización Mundial de la Salud (OMS), las enfermedades cardiovasculares (ECV) se cobraron la vida de 17,9 millones de personas en todo el mundo en 2019, lo que representa el 32% de todas las muertes.

• Aumentar la inversión en infraestructura sanitaria

Otro factor importante que influye en la tasa de crecimiento del mercado de la presbicia es el aumento del gasto sanitario, que contribuye a mejorar su infraestructura. Asimismo, diversas organizaciones gubernamentales tienen como objetivo mejorar la infraestructura sanitaria aumentando la financiación, lo que influirá aún más en la dinámica del mercado.

• Creciente número de población geriátrica

Se estima que el aumento de la población geriátrica impulsará la expansión del mercado durante el período de pronóstico de 2022 a 2029. Según la Organización Mundial de la Salud (OMS), se espera que la población geriátrica mundial, estimada en más de 524 millones en 2010, aumente a casi 2 mil millones para 2050. Debido a sus sistemas inmunológicos comprometidos, los geriátricos son más susceptibles a las enfermedades de presbicia, lo que se estima que impulsará aún más la tasa de crecimiento del mercado.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the presbyopia market. Additionally, the sedentary lifestyle of people and rising disposable income will result in the expansion of presbyopia market. Surging consumption of various medications such as antidepressants, diuretics and antihistamines is the major factor anticipated to flourish the 'market's growth rate during the forecast period of 2022-2029.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the presbyopia market growth. Along with this, rising drug approvals and launches will further propel the 'market's growth rate. 

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the presbyopia market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the treatment will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the presbyopia market. Additionally, strict regulatory policies and lack of awareness among people will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.

This presbyopia market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the presbyopia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Presbyopia appears typically at the age of 40 and gets progressively worse until the late 60s, when it usually levels off. Both men and women are affected equally by presbyopia.

Presbyopia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Presbyopia Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The presbyopia market was hampered by the supply chain slowness.

Recent Development

• In October 2021, Allergan announced the U.S. Food and Drug Administration (FDA) approval of VUITY (pilocarpine HCl ophthalmic solution) 1.25%. It is used for treating presbyopia, commonly known as age-related blurry near vision, in adults. VUITY is a prescription eye drop which works by improving near and intermediate vision without impacting distance vision.

Global Presbyopia Market Scope

The presbyopia market is segmented on the basis of diagnosis, treatment, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

• Eye Exam
• Others

Symptoms

• Eye Strain
• Headaches
• Fatigue
• Blurred Vision
• Others

Treatment

• Eyeglasses
• Office Progressives
• Progressive Multifocals
• Bifocals
• Trifocals
• Prescription Reading Glasses
• Contact Lenses
• Modified Monovision
• Monovision Contact Lenses
• Bifocal Contact Lenses
• Refractive Surgery
• Photorefractive Keratectomy (PRK)
• Laser-Assisted Subepithelial Keratectomy (LASEK)
• Laser-Assisted in Situ Keratomileusis (LASIK)
• Conductive Keratoplasty
• Lens Implants
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Presbyopia Market Regional Analysis/Insights

The presbyopia market is analysed and market size insights and trends are provided by country, diagnosis, treatment, symptoms, end-users and distribution channel as referenced above.

The countries covered in the presbyopia market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the presbyopia market because of the high prevalence of presbyopia and technological advancement in the treatment in this region. Additionally, rising healthcare expenditure and presence of major key players will further propel the 'market's growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to increasing number of geriatric population in this region. Also, development of healthcare infrastructure and rising government initiatives will further propel the 'market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Presbyopia Market Share Analysis

The presbyopia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to presbyopia market.

Some of the major players operating in the presbyopia market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France)
• Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Novartis AG (Switzerland)
• AstraZeneca (UK)
• Johnson & Johnson Private Limited (US)
• Sun Pharmaceutical Industries Ltd. (India)
• Merck & Co., Inc. (US)
• Bausch Health Companies Inc. (Canada)
• Allergan (Ireland)
• Abbott (US)
• Alcon Vision LLC (Switzerland)
• Orasis Pharmaceuticals, Inc. (US)
• NIDEK CO., LTD. (Japan)
• Ziemer Ophthalmic Systems (Switzerland)
• ZEISS International (US)

SKU-54541